pI: 9.4629 |
Length (AA): 600 |
MW (Da): 68361 |
Paralog Number:
5
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_127925)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_11405 | Zinc carboxypeptidase family protein |
Caenorhabditis elegans | CELE_F56H1.5 | Protein CCPP-1 |
Drosophila melanogaster | Dmel_CG44533 | Drosophila Nna1 ortholog |
Echinococcus granulosus | EgrG_000352300 | cytosolic carboxypeptidase 1 |
Echinococcus granulosus | EgrG_000261800 | cytosolic carboxypeptidase 2 |
Echinococcus multilocularis | EmuJ_000352300 | |
Homo sapiens | ENSG00000166748 | ATP/GTP binding protein-like 1 |
Homo sapiens | ENSG00000165923 | ATP/GTP binding protein-like 2 |
Homo sapiens | ENSG00000146856 | ATP/GTP binding protein-like 3 |
Homo sapiens | ENSG00000135049 | ATP/GTP binding protein 1 |
Leishmania braziliensis | LbrM.33.0210 | zinc carboxypeptidase, putative,metallo-peptidase, Clan MC, Family M14 |
Leishmania donovani | LdBPK_330210.1 | metallo-peptidase, Clan MC, Family M14, putative |
Leishmania infantum | LinJ.33.0210 | zinc carboxypeptidase, putative,metallo-peptidase, Clan MC, Family M14 |
Leishmania major | LmjF.33.0200 | zinc carboxypeptidase, putative,metallo-peptidase, Clan MC, Family M14 |
Leishmania mexicana | LmxM.32.0200 | zinc carboxypeptidase, putative,metallo-peptidase, Clan MC, Family M14 |
Loa Loa (eye worm) | LOAG_08804 | hypothetical protein |
Mus musculus | ENSMUSG00000038836 | ATP/GTP binding protein-like 3 |
Mus musculus | 244071 | ATP/GTP binding protein-like 1 |
Mus musculus | ENSMUSG00000021557 | ATP/GTP binding protein 1 |
Mus musculus | ENSMUSG00000040812 | ATP/GTP binding protein-like 2 |
Neospora caninum | NCLIV_039720 | zinc carboxypeptidase, putative |
Onchocerca volvulus | OVOC11748 | Cytosolic carboxypeptidase 1 homolog |
Plasmodium berghei | PBANKA_0209700 | zinc-carboxypeptidase, putative |
Plasmodium falciparum | PF3D7_0103400 | zinc-carboxypeptidase, putative |
Plasmodium knowlesi | PKNH_0210100 | zinc-carboxypeptidase, putative |
Plasmodium vivax | PVX_081585 | hypothetical protein, conserved |
Plasmodium yoelii | PY03811 | Homo sapiens KIAA1035 protein-related |
Schistosoma japonicum | Sjp_0004350 | ko:K01290 carboxypeptidase A [EC3.4.17.1], putative |
Schistosoma japonicum | Sjp_0113610 | Cytosolic carboxypeptidase 1, putative |
Schistosoma mansoni | Smp_167640 | peptidase |
Trypanosoma brucei gambiense | Tbg972.10.13020 | zinc carboxypeptidase, putative,metallo- peptidase, Clan MC, Family M14 |
Trypanosoma brucei | Tb927.10.10750 | metallo-peptidase, Clan MC, Family M14, putative |
Trypanosoma congolense | TcIL3000_10_9050 | metallo-peptidase, Clan MC, Family M14, putative |
Trypanosoma cruzi | TcCLB.503583.10 | metallo-peptidase, Clan MC, Family M14, putative |
Trypanosoma cruzi | TcCLB.503489.10 | metallo-peptidase, Clan MC, Family M14, putative |
Toxoplasma gondii | TGME49_265780 | flagellar/basal body protein |
Trichomonas vaginalis | TVAG_027310 | Clan MC, family M14, Zinc carboxypeptidase-like metallopeptidase |
Trichomonas vaginalis | TVAG_483870 | Clan MC, family M14, Zinc carboxypeptidase-like metallopeptidase |
Trichomonas vaginalis | TVAG_021370 | Clan MC, family M14, Zinc carboxypeptidase-like metallopeptidase |
Trichomonas vaginalis | TVAG_247150 | Clan MC, family M14, Zinc carboxypeptidase-like metallopeptidase |
Trichomonas vaginalis | TVAG_453960 | Clan MC, family M14, Zinc carboxypeptidase-like metallopeptidase |
Trichomonas vaginalis | TVAG_045700 | Clan MC, family M14, Zinc carboxypeptidase-like metallopeptidase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.10750 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.10750 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.10750 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.10750 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_0209700 | Plasmodium berghei | Dispensable | plasmo |
TGME49_265780 | Toxoplasma gondii | Probably essential | sidik |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | ATP/GTP binding protein-like 2 | Compounds | References |